Clinical Trial Update: Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study of Cytolytic Viral Activation Therapy (CVAT) in recurrent/metastatic nasopharyngeal carcinoma; the current status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Cytolytic Viral Activation Therapy (CVAT)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 1 | Status: UNKNOWN